The effect of intrapartum penicillin on vaginal group B streptococcus colony counts

American Journal of Obstetrics and Gynecology

Volumn 197, Issue 6, 2007, Pages 583.e1-583.e4

  McNanley, Anna R ^a   Glantz, J Christopher ^a   Hardy, Dwight J ^a   Vicino, David ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

group B streptococcus; intrapartum; penicillin G; vaginal colonization

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; CLINDAMYCIN; GENTAMICIN; PENICILLIN G; VANCOMYCIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIUM CULTURE; CHORIOAMNIONITIS; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HUMAN; INTRAPARTUM CARE; NONHUMAN; PRIORITY JOURNAL; REPEATED DRUG DOSE; SINGLE DRUG DOSE; STREPTOCOCCUS AGALACTIAE; TREATMENT OUTCOME; VAGINA;

EID: 36448944741     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.08.045     Document Type: Article

References (22)

1. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease. MMWR Morb Mortal Wkly Rep 51 (2002) 1-23
2. Edwards M., and Baker C. Group B streptococcal infections. (Chapter 26). In: Remington J., and Klein J. (Eds). Infectious diseases of the fetus and newborn infant. 5th ed. (2001), W. B. Saunders, Philadelphia
3. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Morb Mortal Wkly Rep 45 (1996) 1-24
4. Bray C. Placental transmission of antibiotics. J Obstet Gynaecol Br Commonw 61 (1954) 750-757
5. Colombo D.F., Lew J.L., Pedersen C.A., Johnson J.R., and Fan-Havard P. Optimal timing of ampicillin administration to pregnant women for establishing bactericidal levels in the prophylaxis of group B streptococcus. Am J Obstet Gynecol 194 (2006) 466-470
6. Spaetgens R., DeBella K., Ma D., Robertson S., Mucenski M., and Davies H.D. Perinatal antibiotic usage and changes in colonization and resistance rates of group B streptococcus and other pathogens. Obstet Gynecol 100 (2002) 525-533
7. Merenstein G.B., Todd W.A., Brown G., Yost C.C., and Luzier T. Group B beta-hemolytic streptococcus: randomized controlled treatment study at term. Obstet Gynecol 55 (1980) 315-318
8. Morales W.J., and Lim D. Reduction of group B streptococcal maternal and neonatal infections in preterm pregnancies with premature rupture of membranes through a rapid identification test. Am J Obstet Gynecol 157 (1987) 13-16
9. Bloom S.L., Cox S.M., Bawdon R.E., and Gilstrap L.C. Ampicillin for neonatal group B streptococcal prophylaxis: how rapidly can bactericidal concentrations be achieved?. Am J Obstet Gynecol 175 (1996) 974-976
10. Davis R.L., Hasselquist M.B., Cardenas V., et al. Introduction of the new Centers for Disease Control and Prevention group B streptococcal prevention guideline at a large West Coast health maintenance organization. Am J Obstet Gynecol 184 (2001) 603-610
11. de Cueto M., Sanchez M.J., Sampedro A., Miranda J.A., Herruzo A.J., and Rosa-Fraile M. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol 91 (1998) 112-114
12. Ancona R.J., Ferrieri P., and Williams P.P. Maternal factors that enhance the acquisition of group-B streptococci by newborn infants. J Med Microbiol 13 (1980) 273-280
13. Tuppurainen N., and Hallman M. Prevention of neonatal group B streptococcal disease: Intrapartum detection and chemoprophylaxis of heavily colonized parturients. Obstet Gynecol 73 (1989) 583-587
14. Regan J.A., Klebanoff M.A., Nugent R.P., et al. Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. Am J Obstet Gynecol 174 (1996) 1354-1360
15. Boyer K.M., Gadzala C.A., Kelly P.D., Burd L.I., and Gotoff S.P. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. J Infect Dis 148 (1983) 802-809
16. Badri M.S., Zawaneh S., Cruz A.C., Mantilla G., Baer H., et al. Rectal colonization with group B Streptococcus: relation to vaginal colonization of pregnant women. J Infect Dis 135 (1977) 308-312
17. Mercer B.M., Taylor M.C., Fricke J.L., Baselski V.S., and Sibai B.M. The accuracy and patient preference for self-collected group B Streptococcus cultures. Am J Obstet Gynecol 173 (1995) 1325-1328
18. Goldenberg R.L., McClure E.M., Saleem S., Rouse D., and Vermund S. Use of vaginally administered chlorhexidine during labor to improve pregnancy outcomes. Obstet Gynecol 107 (2006) 1139-1146
19. Facchinetti F., Piccinini F., Mordini B., and Volpe A. Chlorhexidine vaginal flushings versus systemic ampicillin in the prevention of vertical transmission of neonatal group B streptococcus, at term. J Matern Fetal Neonatal Med 11 (2002) 84-88
20. McDuffie Jr. R.S., Blanton S.J., Charland S.L., and Gibbs R.S. The effect of timing of single-dose transplacental ampicillin-sulbactam therapy for prevention of neonatal group B streptococcal colonization and bacteremia in a rabbit model. Am J Obstet Gynecol 175 (1996) 406-410
21. Pyati S.P., Pildes R.S., Jacobs N.M., et al. Penicillin in infants weighing two kilograms or less with early-onset Group B streptococcal disease. N Engl J Med 308 (1983) 1383-1389
22. Boyer K.M., and Gotoff S.P. Prevention of early-onset neonatal group B streptococci disease with selective intrapartum chemoprophylaxis. N Engl J Med 314 (1986) 1665-1669